Pain
Conference Coverage
Small-fiber polyneuropathy may underlie dysautonomia in ME/CFS
Autonomic dysfunction symptoms reported by ME/CFS patients in a pilot study overlap those commonly described by patients with autoimmune-...
Guidelines
AHA on cannabis: No evidence of heart benefits, but potential harms
The American Heart Association emphasizes potential risks and lack of benefits of cannabis for cardiovascular health.
From the Journals
All NSAIDs raise post-MI risk but some are safer than others: Next chapter
A new cohort analysis extends NSAID cautions in high-CV-risk patients to a Korean population. Some question whether the steep climbs in risk seen...
Latest News
NSAID continuation linked to less knee OA pain
Nonsteroidal anti-inflammatory drugs continue to reduce knee osteoarthritis pain more than 3 months after starting treatment.
Feature
Move over supplements, here come medical foods
When it comes to medical foods, the FDA has often looked the other way because the ingredients may already have been proven safe and the danger to...
News from the FDA/CDC
Use of nonopioid pain meds is on the rise
Prescription opioid use declined from 2009 to 2018, but not significantly.
Conference Coverage
Managing pain expectations is key to enhanced recovery
Multimodal approach to postsurgery pain management can reduce or eliminate opioids for certain patient groups.
Guidelines
EULAR gives pointers on intra-articular injection best practices
A task force based the recommendations on a systematic literature review and two surveys of health professionals and patients to help form expert...
Conference Coverage
Opioid use up after TNF inhibitor for inflammatory arthritis
The findings are an “important reminder” to rheumatologists that they should broaden their consideration of other pain treatments and techniques...
Conference Coverage
Tramadol mortality risk in osteoarthritis could outweigh benefits
Higher all-cause mortality, cardiovascular disease, venous thromboembolism, and hip fracture were seen versus NSAIDs in a large, population-based...
From the Journals
Unacceptable RA pain may drop with TNFi treatment but still lingers in many patients
These results lend “some support to a better effect on long-term pain for the biological treatment, compared with triple therapy, [but also show]...